Equillium, Inc. ( EQ) - Stock Earnings
EQ Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
EQ Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -3.8 million USD | — USD |
| 2026Q1 | -5.3 million USD | — USD |
| 2026Q2 | -4.7 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
EQ Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -13.3 million USD | 36.1 million USD |
| 2024 | -8.1 million USD | 41.1 million USD |
| 2025 | -22.4 million USD | 130000 USD |
| 2026 Est. | — | — |
EQ
Price: $2.36
52 week price:
Earnings Per Share: -0.09 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 25774
Market Capitalization: 149.6 million